PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion

A Current challenge in prostate cancer treatment is how to differentiate aggressive disease from indolent prostate cancer. There is an urgent need to identify markers that would accurately distinguish indolent prostate cancer from aggressive disease. The aim of this study was to evaluate the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown-Clay, Joshua D., Shenoy, Deepika N., Timofeeva, Olga, Kallakury, Bhaskar V., Nandi, Asit K., Banerjee, Partha P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558173/
https://www.ncbi.nlm.nih.gov/pubmed/25909225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558173/
https://www.ncbi.nlm.nih.gov/pubmed/25909225

Ejemplares similares